Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP8 | P22894 | 2/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | NOS3 | P29474 | 1/20 | 0.30 |
| ▸ | NOS1 | P29475 | 1/20 | 0.30 |
| ▸ | NOS2 | P35228 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclohexylamine SCHEMBL132343 | 0.82 | MMP8 (0.32) | MMP8MMP1MMP2 | |
| Cyclohexylamine SCHEMBL6935371 | 0.82 | MMP8 (0.32) | MMP8MMP1MMP2 | |
| Cyclohexylamine SCHEMBL28645531 | 0.81 | SIGMAR1 (0.34) | MMP8MMP1ALDH1A1LMNA | |
| SCHEMBL4023692 | 0.78 | LMNA (0.31) | LMNA | |
| SCHEMBL28958504 | 0.77 | EPHX1 (0.36) | ALDH1A1 | |
| SCHEMBL687465 | 0.76 | LMNA (0.32) | LMNA | |
| Cyclohexylamine SCHEMBL4530522 | 0.75 | MMP8 (0.38) | MMP8MMP1ALDH1A1MMP2CYP1A2 | |
| Methylamine SCHEMBL110166 | 0.75 | LMNA (0.41) | LMNA | |
| Hydrazine SCHEMBL28825171 | 0.75 | LMNA (0.41) | LMNA | |
| Cyclohexylamine SCHEMBL2067439 | 0.75 | CYP1A2 (0.42) | MMP8MMP1ALDH1A1MMP2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 440 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028481-A1 | WATERBORNE SILICONE EMULSION, METHOD FOR MAKING SAME, AND COMPOSITIONS COMPRISING SUCH EMULSIONS | MOMENTIVE PERFORMANCE MAT INC (US) | 2026-01-29 | — | — | US | claimed |
| US-20250326910-A1 | METHOD FOR PRODUCING SURFACE-MODIFIED MICRO-FIBRILLATED CELLULOSE | DÄTWYLER SCHWEIZ AG (CH) | 2025-10-23 | — | — | US | claimed |
| EP-4532567-A1 | METHOD FOR PRODUCING SURFACE-MODIFIED MICRO-FIBRILLATED CELLULOSE | Dätwyler Schweiz AG (CH) | 2025-04-09 | — | — | EP | claimed |
| CN-114787952-B | Solid electrolytic capacitor comprising a precoat layer and an intrinsically conductive polymer | 京瓷AVX元器件公司 | 2025-02-11 | — | — | CN | claimed |
| WO-2023225764-A1 | METHOD FOR PRODUCING SURFACE-MODIFIED MICRO-FIBRILLATED CELLULOSE | DÄTWYLER SCHWEIZ AG (CH) | 2023-11-30 | — | — | WO | claimed |
| CN-110191701-B | Composition for enhancing protein strength | 株式会社LG生活健康 | 2023-02-21 | — | — | CN | claimed |
| CN-114787951-A | Tantalum capacitor with enhanced stability | 京瓷AVX元器件公司 | 2022-07-22 | — | — | CN | claimed |
| CN-114787952-A | Solid electrolytic capacitor comprising a precoat and an intrinsically conductive polymer | 京瓷AVX元器件公司 | 2022-07-22 | — | — | CN | claimed |
| WO-2021119088-A1 | TANTALUM CAPACITOR WITH INCREASED STABILITY | AVX CORPORATION (US) | 2021-06-17 | — | — | WO | claimed |
| WO-2021119065-A1 | SOLID ELECTROLYTIC CAPACITOR CONTAINING A PRE-COAT AND INTRINSICALLY CONDUCTIVE POLYMER | AVX CORPORATION (US) | 2021-06-17 | — | — | WO | claimed |
| EP-2488591-A1 | NITRIC OXIDE-RELEASING COATINGS | Novan, Inc. (US) | 2012-08-22 | — | — | EP | claimed |
| WO-2011047013-A1 | NITRIC OXIDE-RELEASING COATINGS | NOVAN, INC. (US) | 2011-04-21 | — | — | WO | claimed |
| US-20110086234-A1 | NITRIC OXIDE-RELEASING COATINGS | NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR | 2011-04-14 | — | — | US | claimed |
| US-20090214618-A1 | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2009-08-27 | — | — | US | claimed |
| EP-1888510-A2 | NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS | The University of North Carolina at Chapel Hill (US) | 2008-02-20 | — | — | EP | claimed |
| US-20060280716-A1 | Cationic aminosilicone emulsions | MOMENTIVE PERFORMANCE MATERIALS INC. | 2006-12-14 | — | — | US | claimed |
| WO-2006128121-A2 | NITRIC OXIDE-RELEASING PARTICLES FOR NITRIC OXIDE THERAPEUTICS AND BIOMEDICAL APPLICATIONS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2006-11-30 | — | — | WO | claimed |
| EP-1230278-B1 | MOISTURE CURABLE, MELT PROCESSIBLE GRAFT ETHYLENE COPOLYMERS | DU PONT (US) | 2005-06-01 | — | — | EP | claimed |
| EP-1230278-A1 | MOISTURE CURABLE, MELT PROCESSIBLE GRAFT ETHYLENE COPOLYMERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-08-14 | — | — | EP | claimed |
| WO-2001034662-A1 | MOISTURE CURABLE, MELT PROCESSIBLE GRAFT ETHYLENE COPOLYMERS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-05-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260028481-A1 | WATERBORNE SILICONE EMULSION, METHOD FOR MAKING SAME, AND COMPOSITIONS COMPRISING SUCH EMULSIONS | SMCHD1, MLST8, SYVN1 | MMP8 2632/4885MMP1 2189/4885ALDH1A1 3396/4885 |
| US-20090214618-A1 | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications | NOS2, NOS3, NOS1 | MMP8 111/4885MMP1 809/4885ALDH1A1 1868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.